Isovasc Medical Ltd

Isovasc Medical is a privately owned medical device company focused on unmet clinical needs for patients with solid cancers. It develops technologies to enable targeted delivery of chemotherapy, specialising in vascular access and isolated perfusion. Its proprietary products provide novel targeted therapies for local drug-delivery across a broad range of solid cancers. The company’s AVAS Arterial Vascular Access System is an implantable vascular access device intended to facilitate repeatable simultaneous multi-catheter peripheral arterial vascular access; it has received CE Mark approval in Europe and TGA approval in Australia. The Stopflow Occlusion Catheter is a three-lumen balloon catheter developed for use in arterial and venous vasculature, enabling regional chemotherapy through targeted delivery of therapeutic agents to an organ or specific area isolated by balloon occlusion. This investigational product has received CE Mark approval in Europe.